• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VEGFR2/Src 激酶抑制剂在单纯疱疹病毒 1 诱导的免疫病理中的抗炎作用。

An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.

机构信息

Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, 1414 Cumberland Avenue, Knoxville, TN 37996-0845, USA.

出版信息

J Virol. 2011 Jun;85(12):5995-6007. doi: 10.1128/JVI.00034-11. Epub 2011 Apr 6.

DOI:10.1128/JVI.00034-11
PMID:21471229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3126288/
Abstract

Corneal neovascularization represents a key step in the blinding inflammatory stromal keratitis (SK) lesion caused by ocular infection with herpes simplex virus (HSV). In this report, we describe a novel approach for limiting the angiogenesis caused by HSV infection of the mouse eye. We show that topical or systemic administration of the Src kinase inhibitor (TG100572) that inhibits downstream molecules involved in the vascular endothelial growth factor (VEGF) signaling pathway resulted in markedly diminished levels of HSV-induced angiogenesis and significantly reduced the severity of SK lesions. Multiple mechanisms were involved in the inhibitory effects. These included blockade of IL-8/CXCL1 involved in inflammatory cells recruitment that are a source of VEGF, diminished cellular infiltration in the cornea, and reduced proliferation and migration of CD4(+) T cells into the corneas. As multiple angiogenic factors (VEGF and basic fibroblast growth factor [bFGF]) play a role in promoting angiogenesis during SK and since Src kinases are involved in signaling by many of them, the use of Src kinase inhibition represents a promising way of limiting the severity of SK lesions the most common cause of infectious blindness in the Western world.

摘要

角膜新生血管是单纯疱疹病毒(HSV)引起眼部感染导致致盲性炎症性基质角膜炎(SK)的关键步骤。在本报告中,我们描述了一种限制 HSV 感染小鼠眼血管生成的新方法。我们发现,局部或全身给予Src 激酶抑制剂(TG100572)可抑制血管内皮生长因子(VEGF)信号通路的下游分子,导致 HSV 诱导的血管生成水平明显降低,并显著减轻 SK 病变的严重程度。多种机制参与了抑制作用。这些机制包括阻断白细胞介素-8(IL-8)/趋化因子(CXCL1),IL-8/CXCL1 参与招募炎症细胞,而炎症细胞是 VEGF 的来源,减少角膜中的细胞浸润,以及减少 CD4(+)T 细胞向角膜的增殖和迁移。由于多种血管生成因子(VEGF 和碱性成纤维细胞生长因子[bFGF])在促进 SK 期间的血管生成中发挥作用,并且 Src 激酶参与其中许多因子的信号转导,因此抑制 Src 激酶代表了一种有前途的方法,可以限制 SK 病变的严重程度,SK 病变是西方世界感染性失明的最常见原因。

相似文献

1
An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.VEGFR2/Src 激酶抑制剂在单纯疱疹病毒 1 诱导的免疫病理中的抗炎作用。
J Virol. 2011 Jun;85(12):5995-6007. doi: 10.1128/JVI.00034-11. Epub 2011 Apr 6.
2
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.前沿科学:阿司匹林触发的消退素D1控制单纯疱疹病毒诱导的角膜免疫病理学
J Leukoc Biol. 2017 Nov;102(5):1159-1171. doi: 10.1189/jlb.3HI1216-511RR. Epub 2017 Jun 5.
3
Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.用脂源性介质消退素 E1 控制单纯疱疹病毒引起的眼部炎症病变。
J Immunol. 2011 Feb 1;186(3):1735-46. doi: 10.4049/jimmunol.1003456. Epub 2010 Dec 27.
4
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.miR-132 在单纯疱疹病毒眼部感染后血管生成中的作用。
Am J Pathol. 2012 Aug;181(2):525-34. doi: 10.1016/j.ajpath.2012.04.014. Epub 2012 May 31.
5
Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.基于血管内皮生长因子受体2的DNA免疫接种通过抗血管生成作用延缓疱疹性基质性角膜炎的发展。
J Immunol. 2006 Sep 15;177(6):4122-31. doi: 10.4049/jimmunol.177.6.4122.
6
Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.编码白细胞介素-18的质粒DNA的应用通过抗血管生成作用减少疱疹性基质性角膜炎的发展。
J Immunol. 2005 Jul 1;175(1):509-16. doi: 10.4049/jimmunol.175.1.509.
7
Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).贝伐单抗(阿瓦斯汀)在疱疹性基质性角膜炎(HSK)中的治疗潜力。
Med Hypotheses. 2007;69(3):568-70. doi: 10.1016/j.mehy.2007.01.032. Epub 2007 Mar 21.
8
Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function.阿扎胞苷治疗通过增强调节性T细胞功能抑制疱疹性基质性角膜炎的进展。
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.02367-16. Print 2017 Apr 1.
9
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.CXCR2基因敲除小鼠对疱疹性基质性角膜炎的易感性增强:白细胞介素-6诱导的新生血管形成的作用。
J Immunol. 2004 Jan 15;172(2):1237-45. doi: 10.4049/jimmunol.172.2.1237.
10
Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology.神经保护素 D1 可降低单纯疱疹病毒诱导的角膜免疫病理的严重程度。
Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6269-79. doi: 10.1167/iovs.13-12152.

引用本文的文献

1
An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application.单纯疱疹病毒 1 型感染相关疾病的治疗及疫苗研发、载体治疗应用的最新综述
Virulence. 2024 Dec;15(1):2425744. doi: 10.1080/21505594.2024.2425744. Epub 2024 Nov 13.
2
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.角膜单纯疱疹病毒 1 感染和疱疹性基质性角膜炎的免疫生物学。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0000624. doi: 10.1128/cmr.00006-24. Epub 2024 Jul 30.
3
The role, relevance and management of immune exhaustion in bovine infectious diseases.牛传染病中免疫耗竭的作用、相关性及管理
Heliyon. 2024 Mar 27;10(7):e28663. doi: 10.1016/j.heliyon.2024.e28663. eCollection 2024 Apr 15.
4
Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis.眼部表面先天性干扰素反应在单纯疱疹病毒1型诱导的疱疹性基质性角膜炎中的作用
Pathogens. 2023 Mar 10;12(3):437. doi: 10.3390/pathogens12030437.
5
Gene Expression Signatures Reveal Common Virus Infection Pathways in Target Tissues of Type 1 Diabetes, Hashimoto's Thyroiditis, and Celiac Disease.基因表达谱揭示 1 型糖尿病、桥本甲状腺炎和乳糜泻患者目标组织中的常见病毒感染途径。
Front Immunol. 2022 Jun 20;13:891698. doi: 10.3389/fimmu.2022.891698. eCollection 2022.
6
Healing of Ocular Herpetic Disease Following Treatment With an Engineered FGF-1 Is Associated With Increased Corneal Anti-Inflammatory M2 Macrophages.经工程化 FGF-1 治疗后眼部疱疹性疾病的愈合与角膜抗炎 M2 巨噬细胞增多有关。
Front Immunol. 2021 May 13;12:673763. doi: 10.3389/fimmu.2021.673763. eCollection 2021.
7
Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity.骨桥蛋白表达缺失可减少 HSV-1 诱导的角膜混浊。
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):24. doi: 10.1167/iovs.61.10.24.
8
Host-Directed Antiviral Therapy.宿主导向性抗病毒治疗
Clin Microbiol Rev. 2020 May 13;33(3). doi: 10.1128/CMR.00168-19. Print 2020 Jun 17.
9
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.靶向 SARS-CoV-2 病毒 RNA 2'-O-甲基化的早期先天免疫逃避的潜在药物。
Viruses. 2020 May 10;12(5):525. doi: 10.3390/v12050525.
10
Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea.单纯疱疹病毒-1(HSV-1)感染角膜引发的病理过程。
Cell Mol Life Sci. 2019 Feb;76(3):405-419. doi: 10.1007/s00018-018-2938-1. Epub 2018 Oct 16.

本文引用的文献

1
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor.单纯疱疹病毒 1 型感染引起的眼部新生血管是由于血管内皮生长因子 A 与其可溶性受体结合的破坏。
J Immunol. 2011 Mar 15;186(6):3653-65. doi: 10.4049/jimmunol.1003239. Epub 2011 Feb 16.
2
VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability.VEGFR2 和Src 激酶抑制剂抑制安第斯病毒诱导的内皮细胞通透性。
J Virol. 2011 Mar;85(5):2296-303. doi: 10.1128/JVI.02319-10. Epub 2010 Dec 22.
3
Src kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonists.Src 激酶对于 Toll 样受体激动剂激活的人树突状细胞中 IL-12/IL-23 的平衡产生是必需的。
PLoS One. 2010 Jul 9;5(7):e11491. doi: 10.1371/journal.pone.0011491.
4
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.在动物模型中,局部应用贝伐单抗(抗 VEGF)和舒尼替尼(抗 VEGF 和抗 PDGF)抑制角膜新生血管形成。
Am J Ophthalmol. 2010 Oct;150(4):519-528.e1. doi: 10.1016/j.ajo.2010.04.024. Epub 2010 Jun 29.
5
Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model.中性粒细胞通过在体内角膜模型中释放预先形成的 VEGF 促进炎症性血管生成。
Cell Tissue Res. 2010 Feb;339(2):437-48. doi: 10.1007/s00441-009-0908-5. Epub 2009 Dec 12.
6
Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis.抗血管内皮生长因子单克隆抗体诱导单纯疱疹性基质性角膜炎兔模型中角膜新生血管化和炎症的消退
Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1409-16. doi: 10.1007/s00417-009-1101-y. Epub 2009 Aug 5.
7
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.Src家族激酶作为内皮通透性的介质:对炎症和转移的影响
Cell Tissue Res. 2009 Jan;335(1):249-59. doi: 10.1007/s00441-008-0682-9. Epub 2008 Sep 25.
8
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.通过局部应用新型VEGFR2/Src激酶抑制剂抑制小鼠和兔子的视网膜血管通透性
J Clin Invest. 2008 Jun;118(6):2337-46. doi: 10.1172/JCI33361.
9
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.多靶点激酶抑制剂的局部给药可抑制脉络膜新生血管形成和视网膜水肿。
J Cell Physiol. 2008 Jul;216(1):29-37. doi: 10.1002/jcp.21426.
10
VEGF-A and the induction of pathological angiogenesis.血管内皮生长因子-A与病理性血管生成的诱导
Annu Rev Pathol. 2007;2:251-75. doi: 10.1146/annurev.pathol.2.010506.134925.